319 related articles for article (PubMed ID: 11996323)
1. Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.
Asano T; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Kuroiwa Y; Fujii Y; Yamashita M; Kuramochi T; Tomisawa H; Tateishi M
Eur J Drug Metab Pharmacokinet; 2002; 27(1):17-27. PubMed ID: 11996323
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats.
Asano T; Watanabe J; Sadakane C; Ishihara K; Hirakura K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Fujii Y; Yamashita M
Eur J Drug Metab Pharmacokinet; 2002; 27(1):29-35. PubMed ID: 11996324
[TBL] [Abstract][Full Text] [Related]
3. Single dose pharmacokinetics of syrup of ipecac.
Scharman EJ; Hutzler JM; Rosencrance JG; Tracy TS
Ther Drug Monit; 2000 Oct; 22(5):566-73. PubMed ID: 11034262
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of ipecac alkaloids in human volunteers.
Yamashita M; Yamashita M; Azuma J
Vet Hum Toxicol; 2002 Oct; 44(5):257-9. PubMed ID: 12361104
[TBL] [Abstract][Full Text] [Related]
5. Absorption of ipecac alkaloids in emergency patients.
Moran DM; Crouch DJ; Finkle BS
Ann Emerg Med; 1984 Dec; 13(12):1100-2. PubMed ID: 6150666
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic assay with fluorescence detection for the determination of cephaeline and emetine in human plasma and urine.
Asano T; Sadakane C; Ishihara K; Yanagisawa T; Kimura M; Kamei H
J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):197-206. PubMed ID: 11417863
[TBL] [Abstract][Full Text] [Related]
7. Studies for the emetic mechanisms of ipecac syrup (TJN-119) and its active components in ferrets: involvement of 5-hydroxytryptamine receptors.
Hasegawa M; Sasaki T; Sadakane K; Tabuchi M; Takeda Y; Kimura M; Fujii Y
Jpn J Pharmacol; 2002 Jun; 89(2):113-9. PubMed ID: 12120752
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of emetic and United State pharmacopoeia ipecac syrup in prevention of drug absorption.
Teshima D; Suzuki A; Otsubo K; Higuchi S; Aoyama T; Shimozono Y; Saita M; Noda K
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2242-5. PubMed ID: 1980639
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of ipecac alkaloids cephaeline and emetine by human hepatic microsomal cytochrome P450s, and their inhibitory effects on P450 enzyme activities.
Asano T; Kushida H; Sadakane C; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T
Biol Pharm Bull; 2001 Jun; 24(6):678-82. PubMed ID: 11411558
[TBL] [Abstract][Full Text] [Related]
12. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological aspects of ipecac syrup (TJN-119)-induced emesis in ferrets.
Endo T; Nemoto M; Ogawa T; Tamakai H; Hamaue N; Hirafuji M; Takeda Y; Hasegawa M; Fugii Y; Minami M
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):187-200. PubMed ID: 11913711
[TBL] [Abstract][Full Text] [Related]
14. Studies on the metabolism and toxicity of dinitrotoluenes--on the absorption and excretion of tritium-labelled 2,4-dinitrotoluene (3H-2, 4-DNT) in the rat.
Mori M; Naruse Y; Kozuka H
Radioisotopes; 1978 Dec; 27(12):715-9. PubMed ID: 746173
[TBL] [Abstract][Full Text] [Related]
15. Absorption, tissue distribution, and excretion of 3H-labeled arbaprostil in the male rat.
Sinha AJ; Shaw SR; Thornburgh BA
Eur J Drug Metab Pharmacokinet; 1985; 10(2):171-7. PubMed ID: 4043145
[TBL] [Abstract][Full Text] [Related]
16. Toxicology of ipecac: a review.
Manno BR; Manno JE
Clin Toxicol; 1977; 10(2):221-42. PubMed ID: 15766
[TBL] [Abstract][Full Text] [Related]
17. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
[TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
